This is a community-generated profile. If you would like to claim it, please .
DiscoverStartupsArrowhead PharmaceuticalsArrowhead Pharmaceuticals Funding Rounds, Valuation & Investors
Arrowhead Pharmaceuticals company logo
Develops RNAi-based drugs to treat diseases with a genetic origin501-1000 Employees

Arrowhead Pharmaceuticals Funding

$325M
11 round
Arrowhead Pharmaceuticals is active in the following markets / industries: B2B and manufacturing. The company has secured funding across 1 rounds, totaling in an amount of $325M. Their most recent funding was raised on November 26, 2024.

Funding Rounds

S
$325000000

Investors of Arrowhead Pharmaceuticals

Vincent Jakob
Avatar for Vincent Jakob
Internships - Dusseldorf/Cologne; Commercial vocational training - Cologne; Undergraduate Degree - Dusseldorf; Master Degree - London/Shanghai/New York